Immunoregulatory effect of evodiamine in mice of various germlines.
- Author:
Hai-Yan HU
1
;
Zhao-Yang SONG
;
Lan DENG
;
Mei-Xia ZHANG
Author Information
1. Hematology Department, Zhujiang Hospital, Nanfang Medical University, Guangzhou 510282, Guangdong Province, China.
- Publication Type:Journal Article
- MeSH:
Adjuvants, Immunologic;
pharmacology;
Animals;
Cyclin-Dependent Kinase 2;
genetics;
metabolism;
Drugs, Chinese Herbal;
chemistry;
Male;
Mice;
Mice, Inbred BALB C;
Mice, Inbred C57BL;
Plant Extracts;
isolation & purification;
pharmacology;
Proto-Oncogene Proteins c-bcl-2;
genetics;
metabolism;
Quinazolines;
isolation & purification;
pharmacology;
RNA, Messenger;
genetics;
metabolism;
Species Specificity;
Spleen;
cytology;
immunology;
Thymus Gland;
cytology;
immunology
- From:
Journal of Experimental Hematology
2008;16(4):886-891
- CountryChina
- Language:English
-
Abstract:
The aim of this study was to investigate the effect of evodiamine on the proliferation and the immune function of thymocytes and splenocyte of mice from three germlines, which were 8 weeks old masculinity BALB/c, C57BL/6 and F1 hybridization mice. Cells of thymus and spleen were harvested and prepared as unicellular suspension. Cell proliferation was detected by MTT method, while the concentration of IL-2 was detected by ELISA, mRNA levels of bcl-2 and cdk2 in cells treated with evodiamine were detected by RT-PCR, the apoptosis rate and intracellular reactive oxygen species (ROS) concentration were analyzed by FCM, and the protein levels of BCL-2, CDK2 and BAX were determined by fluorescence microscope. The results indicated that at 0.5, 0.75 and 1 micromol/L, evodiamine inhibited the proliferation and externalization of thymocytes and splenocytes stimulated with ConA (p < 0.05). At 0.75 micromol/L, evodiamine inhibited the secretion of IL-2, decreased the mRNA level of bcl-2 and cdk2, and induced apoptosis of thymocytes and splenocytes (p < 0.05). Intracellular ROS concentration increased significantly after treatment with evodiamine for 12 hours (p < 0.05). The death rate increased at a prolong period of time. After treatment with evodiamine for 24 and 48 hours, the cells were divided into two groups, one of which was negatively stained by 2 7-dichlorofluorescein (DCF), which indicated that ROS level decreased significantly in the dying cells. It is concluded that evodiamine inhibits proliferation and induces apoptosis of thymocytes and splenocytes from different germline mice, and at the same time decreases secretion of IL-2 through down-regulating bcl-2 and cdk2 levels.
